Bank & Trust Company’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Bank & Trust Company’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50	Closed	-$2	–	302
2025 Q2	$2	Buy	+50	New	+$20	﹤0.01%	288
2025 Q1	–	Sell	-50	Closed	-$263	–	291
2024 Q4	$263	Hold	50	–	–	﹤0.01%	284
2024 Q3	$716	Hold	50	–	–	﹤0.01%	283
2024 Q2	$810	Buy	+50	New	+$1.25K	﹤0.01%	284

Bank & Trust Company's VINC Position: Q3 2025 in Review

Bank & Trust Company sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2025, closing a stake of 50 shares — an estimated $2 sold.

Bank & Trust Company first reported a position in VINC in Q2 2024 and held it in 4 quarters. The position peaked at $810 in Q2 2024. 0 funds tracked by Wall St. Rank hold VINC as of Q3 2025.

Bank & Trust Company reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Bank & Trust Company sold 50 Vincerx Pharma, Inc. Common Stock shares in Q3 2025, an estimated $2.
Bank & Trust Company first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2024 and held it in 4 quarters.
Bank & Trust Company's Vincerx Pharma, Inc. Common Stock position peaked at $810 in Q2 2024.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2025.

Based on Bank & Trust Company's 13F filing for Q3 2025, filed 6 Oct 2025.